预测和操纵人类肠道细菌Eggerthella lenta的心脏药物失活
Henry J Haiser1, David B Gootenberg, Kelly Chatman
1Faculty of Arts and Sciences Center for Systems Biology, Harvard University, Cambridge, MA 02138, USA.
概括
肠道细菌Eggerthella lenta通过特定的细胞染色体操作子使心脏药物迪戈辛失活化. 饮食中的蛋白质摄入会影响这种微生物代谢,影响体内的药物水平.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 基因组学就是基因组学.
背景情况:
- 人的胃肠道微生物群显著影响药物的疗效和毒性.
- 微生物组与药物相互作用背后的机制往往不太清楚.
研究的目的:
- 阐明肠道Actinobacterium Eggerthella lenta使心脏药物迪戈辛失活化的机制.
- 为了研究宿主饮食对这种微生物药物代谢的影响.
主要方法:
- 暴露于狄戈辛的E. lenta的转录概况.
- 比较基因组学以确定相关的遗传元素.
- 基于培养的测定以确认代谢活动.
- 对 gnotobiotic 小鼠进行的药理动力学研究.
主要成果:
- 在E. lenta中,一个被狄戈辛上调的细胞染色体操作子被确定为狄戈辛失活的关键.
- 这种操作子被阿尔金因抑制,在非代谢菌株中不存在.
- 饮食中的蛋白质被证明可以降低小鼠体内的微生物代谢,改变血清和尿液中的药物度.
结论:
- 埃格雷特拉兰塔 (Eggerthella lenta) 具有特定的消毒素失活机制,其中涉及一个细胞染色体操作子.
- 饮食中的蛋白质摄入量调节了肠道微生物群的体内代谢.
- 药理学结果应该考虑人类和微生物基因组之间的相互作用.
相关概念视频
Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Methods for Studying Drug Absorption: In vitro
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Drug Absorption: Factors Affecting GI Absorption
The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
In...
In...
Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...


